Common Contracts
1 similar null contracts
ContractSeptember 10th, 2020
AMENDMENT # 2 TO CLINICAL TRIAL AGREEMENT DODATOK Č. 2 K ZMLUVE O KLINICKOM SKÚŠANÍ 554/20 Protocol # KHB-1802 Protokol č. KHB-1802 This Amendment # 2 (“Amendment”), effective as of the date following its publication in the central register ofcontracts (“Effective Date”) between Tento dodatok č. 2 (ďalej len „dodatok“), účinný dňom nasledujúcim po dni jeho zverejnenia v centrálnomregistri zmlúv medzi spoločnosťou Syneos Health UK Limited, with principal offices located at Farnborough Business Park, 1 Pinehurst Road, Farnborough, Hampshire, GU14 7BF, United Kingdom, including its affiliates and subsidiaries (“CRO”) Syneos Health UK Limited, s hlavným sídlom podnikania na adrese Farnborough Business Park, 1 Pinehurst Road, Farnborough, Hampshire, GU14 7BF, Velká Británia, vrátane jej pobočiek a dcérskychspoločností (ďalej len „CRO“) and a CHENGDU KANGHONG BIOTECHNOLOGY spoločnosťou CHENGDU KANGHONG CO., LTD., with a principal place of business at 108 BIOTECHNOLOGY CO.,
